Teton Advisors’s Biolase, Inc. BIOL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9
Closed -$21K 452
2019
Q3
$21K Hold
9
﹤0.01% 457
2019
Q2
$32K Hold
9
﹤0.01% 465
2019
Q1
$52K Hold
9
0.01% 463
2018
Q4
$22K Hold
9
﹤0.01% 464
2018
Q3
$46K Sell
9
-3
-25% -$12K ﹤0.01% 470
2018
Q2
$36K Sell
12
-25
-68% -$94.2K ﹤0.01% 461
2018
Q1
$187K Hold
37
0.02% 417
2017
Q4
$196K Buy
37
+10
+37% +$70.3K 0.02% 389
2017
Q3
$206K Hold
27
0.02% 390
2017
Q2
$331K Hold
27
0.03% 336
2017
Q1
$461K Hold
27
0.05% 312
2016
Q4
$478K Hold
27
0.05% 296
2016
Q3
$598K Hold
27
0.05% 350
2016
Q2
$400K Hold
27
0.04% 384
2016
Q1
$447K Hold
27
0.04% 381
2015
Q4
$287K Hold
27
0.03% 425
2015
Q3
$307K Hold
27
0.02% 424
2015
Q2
$594K Hold
27
0.04% 380
2015
Q1
$690K Hold
27
0.05% 362
2014
Q4
$900K Hold
27
0.06% 330
2014
Q3
$852K Hold
27
0.06% 332
2014
Q2
$753K Hold
27
0.05% 367
2014
Q1
$825K Hold
27
0.06% 359
2013
Q4
$964K Hold
27
0.07% 321
2013
Q3
$648K Sell
27
-1
-4% -$32.2K 0.05% 358
2013
Q2
$1.21M Buy
+28
New +$1.57M 0.11% 253

Other funds holding BIOL

Teton Advisors's BIOL Position: Q4 2019 in Review

Teton Advisors sold out of Biolase, Inc. (BIOL) in Q4 2019, closing a stake of 9 shares — an estimated $21K sold.

Teton Advisors first reported a position in BIOL in Q2 2013 and held it in 26 quarters. The position peaked at $1.21M in Q2 2013. 19 funds tracked by Wall St. Rank hold BIOL as of Q4 2019.

  • Teton Advisors reported no remaining Biolase, Inc. position as of Q4 2019 after selling out during the quarter.
  • Teton Advisors sold 9 Biolase, Inc. shares in Q4 2019, an estimated $21K.
  • Teton Advisors first reported a position in Biolase, Inc. in Q2 2013 and held it in 26 quarters.
  • Teton Advisors's Biolase, Inc. position peaked at $1.21M in Q2 2013.
  • 19 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2019.

Based on Teton Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.